Association of prevalent vascular disease with allograft failure and mortality in live-donor kidney transplant recipients – a retrospective cohort study

Rahul Mainra, Germaine Wong, Helen Pilmore, Wai H. Lim

Research output: Contribution to journalArticle

Abstract

Limited data exist regarding the impact of prevalent vascular disease after live-donor kidney transplantation. We aimed to determine the associations between the number of prevalent vascular diseases, allograft, and patient outcomes following live-donor transplantation. This cohort study used data from the Australia and New Zealand Dialysis and Transplant Registry. Rates between recipients of live-donor kidney transplants ± prevalent vascular disease prior to transplantation were calculated. The associations between vascular disease, allograft failure, and all-cause mortality were assessed using Cox regression modeling. Kaplan–Meier proportions were used to calculate all-cause mortality and death with a function graft stratified by vascular disease burden. Of 4742 live-donor recipients, 428 (9%) and 84 (2%) had prevalent vascular disease at 1 and ≥2 sites, respectively. Compared to recipients without vascular disease, the respective adjusted hazard ratios (95% confidence intervals) for patients with vascular disease at 1 and ≥2 sites were 1.78 (1.41–2.25) and 3.02 (2.03–4.50) for all-cause mortality; and 1.54 (1.26–1.88) and 2.28 (1.54–3.38) for allograft failure. All-cause mortality in recipients with vascular disease at 0, 1 and ≥2 sites was 0.028 (0.025, 0.031), 0.090 (0.073, 0.106) and 0.247 (0.196, 0.282) over the first 5-year post-transplant. There was an incremental association between the number of prevalent vascular disease sites and risk of allograft failure and all-cause mortality in live-donor kidney transplant recipients.

Original languageEnglish
JournalTransplant International
DOIs
Publication statusE-pub ahead of print - 26 Jun 2019

Fingerprint

Vascular Diseases
Allografts
Cohort Studies
Retrospective Studies
Tissue Donors
Kidney
Mortality
Transplants
Transplantation
Transplant Recipients
New Zealand
Kidney Transplantation
Registries
Dialysis
Cause of Death
Confidence Intervals

Cite this

@article{5bb60be2def4481592d30ff2f92c7473,
title = "Association of prevalent vascular disease with allograft failure and mortality in live-donor kidney transplant recipients – a retrospective cohort study",
abstract = "Limited data exist regarding the impact of prevalent vascular disease after live-donor kidney transplantation. We aimed to determine the associations between the number of prevalent vascular diseases, allograft, and patient outcomes following live-donor transplantation. This cohort study used data from the Australia and New Zealand Dialysis and Transplant Registry. Rates between recipients of live-donor kidney transplants ± prevalent vascular disease prior to transplantation were calculated. The associations between vascular disease, allograft failure, and all-cause mortality were assessed using Cox regression modeling. Kaplan–Meier proportions were used to calculate all-cause mortality and death with a function graft stratified by vascular disease burden. Of 4742 live-donor recipients, 428 (9{\%}) and 84 (2{\%}) had prevalent vascular disease at 1 and ≥2 sites, respectively. Compared to recipients without vascular disease, the respective adjusted hazard ratios (95{\%} confidence intervals) for patients with vascular disease at 1 and ≥2 sites were 1.78 (1.41–2.25) and 3.02 (2.03–4.50) for all-cause mortality; and 1.54 (1.26–1.88) and 2.28 (1.54–3.38) for allograft failure. All-cause mortality in recipients with vascular disease at 0, 1 and ≥2 sites was 0.028 (0.025, 0.031), 0.090 (0.073, 0.106) and 0.247 (0.196, 0.282) over the first 5-year post-transplant. There was an incremental association between the number of prevalent vascular disease sites and risk of allograft failure and all-cause mortality in live-donor kidney transplant recipients.",
keywords = "all-cause mortality, live-donor kidney transplantation, vascular disease",
author = "Rahul Mainra and Germaine Wong and Helen Pilmore and Lim, {Wai H.}",
year = "2019",
month = "6",
day = "26",
doi = "10.1111/tri.13473",
language = "English",
journal = "Transplant International",
issn = "0934-0874",
publisher = "John Wiley & Sons",

}

TY - JOUR

T1 - Association of prevalent vascular disease with allograft failure and mortality in live-donor kidney transplant recipients – a retrospective cohort study

AU - Mainra, Rahul

AU - Wong, Germaine

AU - Pilmore, Helen

AU - Lim, Wai H.

PY - 2019/6/26

Y1 - 2019/6/26

N2 - Limited data exist regarding the impact of prevalent vascular disease after live-donor kidney transplantation. We aimed to determine the associations between the number of prevalent vascular diseases, allograft, and patient outcomes following live-donor transplantation. This cohort study used data from the Australia and New Zealand Dialysis and Transplant Registry. Rates between recipients of live-donor kidney transplants ± prevalent vascular disease prior to transplantation were calculated. The associations between vascular disease, allograft failure, and all-cause mortality were assessed using Cox regression modeling. Kaplan–Meier proportions were used to calculate all-cause mortality and death with a function graft stratified by vascular disease burden. Of 4742 live-donor recipients, 428 (9%) and 84 (2%) had prevalent vascular disease at 1 and ≥2 sites, respectively. Compared to recipients without vascular disease, the respective adjusted hazard ratios (95% confidence intervals) for patients with vascular disease at 1 and ≥2 sites were 1.78 (1.41–2.25) and 3.02 (2.03–4.50) for all-cause mortality; and 1.54 (1.26–1.88) and 2.28 (1.54–3.38) for allograft failure. All-cause mortality in recipients with vascular disease at 0, 1 and ≥2 sites was 0.028 (0.025, 0.031), 0.090 (0.073, 0.106) and 0.247 (0.196, 0.282) over the first 5-year post-transplant. There was an incremental association between the number of prevalent vascular disease sites and risk of allograft failure and all-cause mortality in live-donor kidney transplant recipients.

AB - Limited data exist regarding the impact of prevalent vascular disease after live-donor kidney transplantation. We aimed to determine the associations between the number of prevalent vascular diseases, allograft, and patient outcomes following live-donor transplantation. This cohort study used data from the Australia and New Zealand Dialysis and Transplant Registry. Rates between recipients of live-donor kidney transplants ± prevalent vascular disease prior to transplantation were calculated. The associations between vascular disease, allograft failure, and all-cause mortality were assessed using Cox regression modeling. Kaplan–Meier proportions were used to calculate all-cause mortality and death with a function graft stratified by vascular disease burden. Of 4742 live-donor recipients, 428 (9%) and 84 (2%) had prevalent vascular disease at 1 and ≥2 sites, respectively. Compared to recipients without vascular disease, the respective adjusted hazard ratios (95% confidence intervals) for patients with vascular disease at 1 and ≥2 sites were 1.78 (1.41–2.25) and 3.02 (2.03–4.50) for all-cause mortality; and 1.54 (1.26–1.88) and 2.28 (1.54–3.38) for allograft failure. All-cause mortality in recipients with vascular disease at 0, 1 and ≥2 sites was 0.028 (0.025, 0.031), 0.090 (0.073, 0.106) and 0.247 (0.196, 0.282) over the first 5-year post-transplant. There was an incremental association between the number of prevalent vascular disease sites and risk of allograft failure and all-cause mortality in live-donor kidney transplant recipients.

KW - all-cause mortality

KW - live-donor kidney transplantation

KW - vascular disease

UR - http://www.scopus.com/inward/record.url?scp=85068714158&partnerID=8YFLogxK

U2 - 10.1111/tri.13473

DO - 10.1111/tri.13473

M3 - Article

JO - Transplant International

JF - Transplant International

SN - 0934-0874

ER -